The cash inflow from expense reimbursements in a collaboration agreement.

No definition available.

Name:	plx_ProceedsFromExpenseReimbursements
Namespace Prefix:	plx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of proceeds from sale of products.

+ References

No definition available.

+ Details

Name:	plx_ProceedsFromSaleOfProducts
Namespace Prefix:	plx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Share based compensation arrangement by share based payment award grant date fair value.

+ References

No definition available.

+ Details

Name:	plx_ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDateFairValue
Namespace Prefix:	plx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of employees to whom plan is granting shares.

+ References

No definition available.

+ Details

Name:	plx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEmployeesReceivingGrantUnderPlan
Namespace Prefix:	plx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of equal quarterly increments over which the awards vest under the share based payment arrangement.

+ References

No definition available.

+ Details

Name:	plx_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfQuarterlyIncrements
Namespace Prefix:	plx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481674/830-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483399/855-10-50-2

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=plx_EmployeeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=plx_PfizerAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=plx_ChiesiAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

SUBSEQUENT EVENTS (Details)		1 Months Ended	2 Months Ended		12 Months Ended
SUBSEQUENT EVENTS (Details)	Mar. 14, 2024 USD ($)	Jan. 31, 2024 USD ($) employee item shares	Mar. 14, 2024 USD ($)	Feb. 29, 2024 USD ($)	Dec. 31, 2023 shares
Restricted Stock \| Employee
Subsequent Event [Line Items]
Number of shares granted \| shares					1,371,362
Subsequent Event \| Pfizer Agreement
Subsequent Event [Line Items]
Proceeds From Sale Of Products			$ 4,600,000
Subsequent Event \| Chiesi Agreements
Subsequent Event [Line Items]
Proceeds from expense reimbursements	$ 300,000			$ 300,000
Subsequent Event \| Restricted Stock \| Employee
Subsequent Event [Line Items]
Vesting period		3 years
Number of shares granted \| shares		100,000
Number of employees granted shares as bonus \| employee		2
Number of equal quarterly increments \| item		12
Grant Date Fair Value		$ 161,000